| Literature DB >> 28905533 |
Kwang Ha Yoo1, Wou Young Chung2, Joo Hun Park3, Sung Chul Hwang2, Tae Eun Kim4, Min Jung Oh5, Dae Ryong Kang5, Chin Kook Rhee6, Hyoung Kyu Yoon6, Tae Hyung Kim7, Deog Kyeom Kim8, Yong Bum Park9, Sang Ha Kim10, Ho Kee Yum11.
Abstract
BACKGROUND: Proper education regarding inhaler usage and optimal management of chronic obstructive pulmonary disease (COPD) is essential for effectively treating patients with COPD. This study was conducted to evaluate the effects of a comprehensive education program including inhaler training and COPD management.Entities:
Keywords: Dry Powder Inhalers; Education; Metered Dose Inhalers; Pulmonary Disease, Chronic Obstructive
Year: 2017 PMID: 28905533 PMCID: PMC5617854 DOI: 10.4046/trd.2017.0041
Source DB: PubMed Journal: Tuberc Respir Dis (Seoul) ISSN: 1738-3536
Figure 1Study design and enrollment. COPD: chronic obstructive pulmonary disease.
Baseline characteristics of enrolled COPD patients
| Variable | COPD (n=127) |
|---|---|
| Age (mean±SD), yr | 67.8±10.1 |
| Male sex | 113 (89.0) |
| Smoking current/former/never, % | 7.8/52.8/19.4 |
| Comorbidities | |
| Hypertension | 61 (48.0) |
| Cardiovascular disorder (angina pectoris, myocardial infarction) | 6 (4.7) |
| Heart failure | 5 (3.9) |
| Arrhythmia | 5 (3.9) |
| Diabetes mellitus | 17 (13.4) |
| Hyperlipidemia | 11 (8.7) |
| Osteoporosis | 3 (2.4) |
| Depression | 7 (5.5) |
| Anemia | 2 (1.6) |
| Inhaler use | |
| Metered dose inhaler | 54 (42.5) |
| Dry power inhaler | 73 (57.5) |
| Turbohaler | 28 (22.1) |
| Diskus | 45 (35.4) |
| Handihaler | 49 (38.6) |
| Soft mist inhaler | 13(10.2) |
| Breezehaler | 7 (5.5) |
| Combination inhaler (ICS+LABA) | 45 (35.4) |
| Combination inhaler (ICS+LABA)+LAMA | 28 (22.0) |
| LABA+LAMA | 2 (1.6) |
| LAMA only | 27 (21.2) |
| LABA only | 2 (1.6) |
| SABA only | 10 (7.0) |
| Previous education for 1 year before visit | |
| About COPD | |
| Never | 76 (60.3) |
| Intermittent (1–2 times) | 27 (21.4) |
| Frequently (≥3 times) | 7 (5.6) |
| Every time | 16 (12.7) |
| About inhaler usage | |
| Never | 56 (44.4) |
| Intermittent (1–2 times) | 43 (34.1) |
| Frequently (≥3 times) | 11 (8.7) |
| Every time | 16 (12.7) |
Values are presented as number (%) unless otherwise indicated.
COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroid; LABA: inhaled long acting β 2 agonist; LAMA: long-acting muscarinic agent; SABA: inhaled short acting β 2 agonist.
Inhaler usage assessed by physicians before and after inhaler training
| Item | Positive answer | p-value | |
|---|---|---|---|
| Before education | After education | ||
| Open the lid correctly | 97/127 (76.4) | 126/127 (99.2) | <0.001 |
| Hold the inhaler correctly | 83/127 (65.4) | 126/127 (99.2) | <0.001 |
| Enough breathing out before inhalation | 41/127 (32.3) | 111/127 (87.4) | <0.001 |
| Understand the manner of inhalation well | 57/127 (44.9) | 122/127 (96.1) | <0.001 |
| Hold their breath for 5 seconds after inhalation | 51/127 (40.2) | 118/127 (92.9) | <0.001 |
| Exhale after fully removing inhaler from mouth | 67/127 (52.8) | 120/127 (94.5) | <0.001 |
| Rinse their mouth after inhaler use | 65/105 (61.9) | 101/103 (98.1) | <0.001 |
Values are presented as number (%).
Figure 2Chronic obstructive pulmonary disease assessment test (CAT) score before and after comprehensive education program (n=125).
(A) Total CAT score (20.1±9.6 vs. 15.7±9.0, p<0.001). (B) 1: I never cough (2.67±1.48 vs. 1.91±1.43, p<0.001); 2: sputum (2.84±1.43 vs. 2.30±1.36, p<0.001); 3: chest tightness (2.34±1.69 vs. 1.75±1.46, p<0.001); 4: dyspnea (3.36±1.42 vs. 2.69±1.54, p<0.001); 5: limitation on home activity (2.08±1.67 vs. 1.39±1.37, p<0.001); 6: confidently leaving my home (2.05±1.60 vs. 1.66±1.48, p=0.008); 7: sleep soundly (2.15±1.68 vs. 1.66±1.53, p=0.001); 8: have lots of energy (2.57±1.47 vs. 2.28±2.30, p=0.189). Values are presented as mean±SD. *p<0.05.
Figure 3Change of knowledge about chronic obstructive pulmonary disease (COPD) before and after comprehensive education program. A: I understand COPD well (45.2% vs. 88.9%, p<0.001); B: COPD is a disease that should be consistently treated (73.8% vs. 98.4%, p<0.001); C: I know about how to cope with sudden aggravation of respiratory symptoms (37.3% vs. 82.5%, p<0.001); D: The most important medicine in the treatment of COPD is inhaler (60.3% vs. 95.2%, p<0.001); E: I know about the method of inhaler use well (69.6% vs. 97.6%, p<0.001); F: I use inhalers regularly according to the physician's advice (69.0% vs. 96.0%, p<0.001). Values of positive answers are presented as percentage. *p<0.05.
Evaluation of CAT change by MCID after the education of inhaler usage
| Items for patients | Change of survey items after education program | ||
|---|---|---|---|
| No change | Positive change | p-value | |
| Open the lid correctly. | 0.018 | ||
| Less than MCID | 40/69 (58.0) | 29/69 (42.0) | |
| MCID improvement or more | 21/56 (37.5) | 35/56 (62.5) | |
| Hold the inhaler correctly. | 0.036 | ||
| Less than MCID | 33/69 (47.8) | 36/69 (52.2) | |
| MCID improvement or more | 17/56 (30.4) | 39/56 (69.6) | |
| Enough breathing out before inhalation. | 0.301 | ||
| Less than MCID | 20/69 (29.0) | 49/69 (71.0) | |
| MCID improvement or more | 13/56 (23.2) | 43/56 (76.8) | |
| Understand the manner of inhalation well. | 0.162 | ||
| Less than MCID | 24/69 (34.8) | 45/69 (65.2) | |
| MCID improvement or more | 14/56 (25.0) | 42/56 (75.0) | |
| Hold their breath for 5 seconds after inhalation. | 0.039 | ||
| Less than MCID | 23/69 (33.3) | 46/69 (66.7) | |
| MCID improvement or more | 10/56 (17.9) | 46/56 (82.1) | |
| Exhale after fully removing inhaler from mouth. | 0.077 | ||
| Less than MCID | 28/69 (40.6) | 41/69 (59.4) | |
| MCID improvement or more | 15/56 (26.8) | 41/56 (73.2) | |
| Rinse their mouth well after inhaler use. | 0.007 | ||
| Less than MCID | 29/57 (50.9) | 28/57 (49.1) | |
| MCID improvement or more | 10/41 (24.4) | 31/41 (75.6) | |
Values are presented as number (%).
Minimum Clinically Important Difference (MCID): improvement of 4 points or more in chronic obstructive pulmonary disease assessment test (CAT) score.
Evaluation of CAT change by MCID after education of the understanding on COPD
| Items for patients | Change of survey items after education program | ||
|---|---|---|---|
| No change | Positive change | p-value | |
| I understand COPD well. | 0.282 | ||
| Less than MCID | 28/69 (40.6) | 41/69 (59.4) | |
| MCID improvement or more | 19/56 (33.9) | 37/56 (66.1) | |
| COPD is a disease that should be consistently treated. | 0.006 | ||
| Less than MCID | 46/69 (66.7) | 23/69 (33.3) | |
| MCID improvement or more | 24/56 (42.9) | 32/56 (57.1) | |
| I know about how to cope with sudden aggravation of respiratory symptoms. | 0.203 | ||
| Less than MCID | 27/69 (39.1) | 42/69 (60.9) | |
| MCID improvement or more | 17/56 (30.4) | 39/56 (69.6) | |
| The most important medicine in the treatment of COPD is inhaler. | 0.017 | ||
| Less than MCID | 35/69 (50.7) | 34/69 (49.3) | |
| MCID improvement or more | 17/56 (30.4) | 39/56 (69.6) | |
| I know about the method of inhaler usage well. | <0.001 | ||
| Less than MCID | 48/68 (70.6) | 20/68 (29.4) | |
| MCID improvement or more | 22/56 (37.5) | 34/56 (62.5) | |
| I use inhalers regularly according to the physician’s advice. | <0.001 | ||
| Less than MCID | 49/69 (71.0) | 20/69 (29.0) | |
| MCID improvement or more | 22/56 (39.3) | 34/56 (60.7) | |
Values are presented as number (%).
Minimum Clinically Important Difference (MCID): improvement of 4 points or more of chronic obstructive pulmonary disease assessment test (CAT) score.